Maryll Geherty
About Maryll Geherty
Maryll Geherty is a Principal Scientist at Bristol Myers Squibb with a strong background in organic chemistry and extensive experience in the pharmaceutical industry, including multiple roles at Celgene.
Company
Maryll Geherty is currently working at Bristol Myers Squibb as a Principal Scientist. She joined the company in October 2020. Bristol Myers Squibb is a global biopharmaceutical company that focuses on the development of innovative medicines aimed at addressing some of the most challenging diseases.
Job Titles
Maryll Geherty holds multiple roles in the pharmaceutical industry. She is the Principal Scientist at Bristol Myers Squibb. She also serves as Senior Scientist, Scientist II, and Scientist I at Celgene. Her work at Celgene has equipped her with extensive experience in various scientific capacities, particularly in Summit, NJ.
Education and Expertise
Maryll Geherty has a strong educational background in chemistry. She achieved a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Pittsburgh, where she studied from 2007 to 2012. Prior to that, she earned a Bachelor of Science (BS) degree in Chemistry from The College of New Jersey, studying there from 2003 to 2007.
Background in Academic Research
Maryll Geherty has substantial academic research experience. She worked as a Postdoctoral Research Scientist at Princeton University from 2013 to 2014. During her time at the University of Pittsburgh, she was a Graduate Student from 2007 to 2012, focusing on organic chemistry.
Professional Background in Pharmaceuticals
Maryll Geherty has built a comprehensive career in the pharmaceutical industry. She held various scientific roles at Celgene, progressing from Scientist I to Senior Scientist. This extensive experience highlights her capability and expertise in the field, particularly within a professional environment that demands high-level scientific knowledge and research skills.